Structure Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	Current	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	2,139	1,891	-	-	-
Market Cap Growth	119.52%	-	-	-	-
Enterprise Value	1,705	1,429	-91	-107	-37
PE Ratio	-	-21.10	-	-	-
PB Ratio	4.97	4.17	-	-	-
P/FCF Ratio	-20.89	-23.15	-	-	-
P/OCF Ratio	-21.42	-23.79	-	-	-
EV/EBITDA Ratio	-16.31	-16.15	1.79	2.70	2.36
EV/EBIT Ratio	-16.07	-15.99	1.77	2.68	2.36
EV/FCF Ratio	-16.38	-17.50	1.96	3.20	2.60
Debt / Equity Ratio	0.01	0.01	0.00	-0.01	-0.01
Debt / EBITDA Ratio	-0.05	-0.06	-0.01	-0.02	-0.02
Debt / FCF Ratio	-0.05	-0.07	-0.01	-0.02	-0.02
Quick Ratio	18.50	18.89	6.98	12.39	12.32
Current Ratio	19.05	19.14	7.16	12.62	12.64
Return on Equity (ROE)	-30.30%	-32.70%	58.70%	100.40%	-
Return on Assets (ROA)	-28.20%	-30.50%	-50.60%	-58.40%	-
Return on Capital (ROIC)	-26.47%	-22.42%	45.75%	58.80%	71.68%
Earnings Yield	-4.57%	-4.74%	-	-	-
FCF Yield	-4.48%	-4.32%	-	-	-
Buyback Yield / Dilution	-94.98%	-1049.81%	-17.73%	-30.01%	-
Total Shareholder Return	-94.98%	-1049.81%	-17.73%	-30.01%	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).